(OP: SDZXF )

39.37 UNCHANGED

Streaming Delayed Price Updated: 10:39 AM EDT, Apr 21, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	39.37
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	39.37
Today's Range	39.37 - 39.37
52wk Range	31.84 - 49.83
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug

April 14, 2025

Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the inflammatory disease market.

Via Benzinga

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

February 24, 2025

Multiple sclerosis patients report severe side effects, including relapses and mobility issues, after switching from Tysabri to Tyruko in an NHS cost-saving move. Regulators and experts are assessing...

Via Benzinga

Performance

YTD	-3.86%	-3.86%
1 Month	-9.34%	-9.34%
3 Month	-16.21%	-16.21%
6 Month	-10.83%	-10.83%
1 Year	+20.02%	+20.02%

More News

Why Is Coherus BioSciences Stock Trading Higher On Tuesday?

December 03, 2024

Via Benzinga

UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars

September 11, 2024

Via Benzinga

Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab

April 30, 2024

Via Benzinga

February 29, 2024

Via Benzinga

Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?

January 22, 2024

Via Benzinga

Venue Turmoil: Pharma Companies Oppose States' Bid to Relocate Price-Fixing Cases

December 04, 2023

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.